Published by Coherent Market Insights
Posted on September 28, 2021
4 min readLast updated: February 1, 2026
The Remote Patient Monitoring Devices market is expanding due to new product developments and rising chronic disease cases, offering growth opportunities.
Patient monitoring refers to the collection and analysis of medical data from one or more health settings (such as in hospitals or doctor’s offices) for use by health care providers and other professionals in order to detect changes in an individual’s medical status and to provide treatment options as needed. In health care, patient monitoring is generally the measurement of one or more medical parameters over extended periods of time, usually at different health care settings (such as in doctor’s offices or hospitals).
Patient monitoring may be implemented in many different health care settings including primary care offices, emergency rooms, doctors’ offices, nursing homes, private practices, and government agencies. Most patient monitoring systems contain software that collect and store medical data in a database that is accessible to multiple health care providers and to health care facilities.
Key Players Profiled in the Remote Patient Monitoring Devices Market Report are as follows: Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic PLC., Nihon Kohden, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., and St. Jude Medical.
Request Sample Copy of Remote Patient Monitoring Devices Report @
https://www.coherentmarketinsights.com/insight/request-sample/215
High prevalence of chronic disorders is expected to propel growth of the global remote patient monitoring devices market over the forecast period. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
Approval and launch of new products is also expected to aid in growth of the global remote patient monitoring devices market over the forecast period. For instance, in April 2019, the U.S. Food and Drug Administration (FDA) granted Class II clearance for Current Health (a healthcare company)’s Artificial Intelligence (AI)-based wearable remote patient monitoring platform (RPM), for post-acute care in hospital and home care setting.
Increasing geriatric population is expected to offer lucrative growth opportunities for players operating in the global remote patient monitoring devices market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Request for Customization:
https://www.coherentmarketinsights.com/insight/request-customization/215
Key players are focused on launching new devices for patient monitoring, in order to meet unmet needs in the healthcare sector, which is expected to drive the global remote patient monitoring devices market growth. For instance, in February 2019, AT&T Inc., a U.S.-based multinational company launched a new smart watch, One Pulse, designed with telehealth and remote patient monitoring capabilities. This smart watch helps in monitoring real-time alerts for family and physicians, medication reminders, and prescription refills. It also provides medical records, which can be accessed through a cloud-based software and application programming interface that allows connectivity to any electronic health record platform.
Moreover, in September 2019, India-based Sanskritech Smart Solutions Private Limited, a healthcare startup launched an advanced self-monitoring, health diagnostic Point-of-care testing (POCT) system ‘Swayam AHM’, which is an ATM-like kiosk that helps people to walk in and take 55 basic and advanced pathology tests with instant test reports.
The report answers questions such as:
• What is the market size and forecast of the Remote Patient Monitoring Devices market?
• What are the inhibiting factors and impact of COVID-19 shaping the Remote Patient Monitoring Devices market during the forecast period?
• Which are the products/segments/applications/areas to invest in over the forecast period in the Remote Patient Monitoring Devices market?
• What is the competitive strategic window for opportunities in the Remote Patient Monitoring Devices market?
• What are the technology trends and regulatory frameworks in the Remote Patient Monitoring Devices market?
• What are the modes and strategic moves considered suitable for entering the Remote Patient Monitoring Devices market?
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact us:
Mr. Shah
Senior Client Partner – Business Development
sales@coherentmarketinsights.com
www.coherentmarketinsights.com
The post Remote Patient Monitoring Devices Market – Increasing demand in new product developments by manufacturers is expected to boost the growth of the market appeared first on Gatorledger.
The article discusses the growth and trends in the Remote Patient Monitoring Devices market.
Market growth is driven by new product developments and the rising prevalence of chronic diseases.
Key players include Abbott Laboratories, GE Healthcare, Omron Healthcare, and Medtronic PLC.
Explore more articles in the Research Reports category
